cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Nautilus Biotechnology Inc
3 own
5 watching
Current Price
$1.99
$0.02
(1.02%)
logo-naut
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
248.2M
52-Week High
52-Week High
5.065
52-Week Low
52-Week Low
1.5
Average Volume
Average Volume
0.19M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization248.2M
icon52-Week High5.065
icon52-Week Low1.5
iconAverage Volume0.19M
iconDividend Yield--
iconP/E Ratio--
What does the Nautilus Biotechnology Inc do?
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Read More
How much money does Nautilus Biotechnology Inc make?
News & Events about Nautilus Biotechnology Inc.
Globe Newswire
3days ago
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year of 2022 before market open on Thursday, ...
Globe Newswire
3days ago
Proteomics company opens new office in Southern California to facilitate ongoing research and team growth aimed at unlocking the potential of the proteome Nautilus Biotechnology - San Diego University Town Center in San Diego, California Nick Nelson SVP and Chief Business Officer SEATTLE, ...
Globe Newswire
10days ago
Collaboration enables TGen to gain access to data generated on prototype versions of Nautilus next-generation proteome analysis platform to advance the study of a rare childhood cancerSEATTLE, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company ...
GeekWire
1month ago
Banzai, a Seattle marketing software startup, announced Thursday that it will go public after it agreed to merge with a special-purpose acquisition company. The company also said that it will pay $110 million to acquire marketing optimization startup Hyros after the SPAC deal closes. Founded in 2016...
Market News Video
2 months ago
In trading on Thursday, shares of Nautilus Biotechnology Inc (NAUT) touched a new 52-week low of 1.82/share. Thats a 4.47 share price drop, or -71.07% decline from the 52-week high of 6.29 set back on 12/27/2021...
Frequently Asked Questions
Frequently Asked Questions
What is Nautilus Biotechnology Inc share price today?
plus_minus_icon
Can Indians buy Nautilus Biotechnology Inc shares?
plus_minus_icon
How can I buy Nautilus Biotechnology Inc shares from India?
plus_minus_icon
Can Fractional shares of Nautilus Biotechnology Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Nautilus Biotechnology Inc stocks?
plus_minus_icon
What is today’s traded volume of Nautilus Biotechnology Inc?
plus_minus_icon
What is today’s market capitalisation of Nautilus Biotechnology Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Nautilus Biotechnology Inc?
plus_minus_icon
What percentage is Nautilus Biotechnology Inc down from its 52-Week High?
plus_minus_icon
What percentage is Nautilus Biotechnology Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.99
$0.02
(1.02%)
logo-naut
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00